Fundraising Fox
/Companies
Sign in

OmniPulse Biosciences

Cambridge, US · Founded 2022 · 1 known investors

Find your way into OmniPulse Biosciences

A biotech company developing a multi-layered polymer delivery system for sustained-release vaccine and medication administration via single injection.

Biotech

Founders & leadership

OmniPulse Biosciences was founded in 2022 by Ana Jacklenec and Robert Farra.

AJ
Ana JacklenecCo-founder
RF
Robert FarraCo-founder

Board

DZDavid Zhu
David ZhuBoard directorFounding Partner at Kendall Capital Partners
FH
Felicia HsuBoard director
RLRobert Langer
Robert LangerBoard directorScientific Advisory Committee Member at Polaris Partners

Investors · 1

Reported raises · per SEC filings

Form D private placements

$7M disclosed across 1 round · 2023

▶$7MraisedJan 2024 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ana JacklenecDirector, Promoter
  • David ZhuDirector
  • Robert FarraExecutive Officer, Director
  • Joseph DeSimonePromoter
  • Felicia HsuDirector
  • Robert LangerDirector, Promoter
Offering amount
$12.5M
Amount sold
$7M
Proceeds to insiders
$1.4M
First sale
Dec 2023
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does OmniPulse Biosciences do?
A biotech company developing a multi-layered polymer delivery system for sustained-release vaccine and medication administration via single injection.
Who founded OmniPulse Biosciences?
OmniPulse Biosciences was founded by Ana Jacklenec, Robert Farra in 2022.
Who are OmniPulse Biosciences's investors?
OmniPulse Biosciences's investors include Kendall Capital Partners.
How much funding has OmniPulse Biosciences raised?
OmniPulse Biosciences has disclosed $7M raised across 1 round.
Where is OmniPulse Biosciences headquartered?
OmniPulse Biosciences is headquartered in Cambridge, US.